Cannabis Campaigners' Guide News Database result:


After you have finished reading this article you can click here to go back.

UK: Clarke rules out cannabis reclassification

David Batty

The Guardian

Thursday 19 Jan 2006

---
The home secretary, Charles Clarke, today ruled out another
reclassification of cannabis despite recent warnings that the drug can
cause serious mental illness.

Mr Clarke said cannabis would not be changed back to a class B drug,
instead announcing a public health campaign to warn people of the health
risks associated with its use.

He told MPs that his decision to keep cannabis as a class C drug had
followed advice from the Advisory Council on the Misuse of Drugs, and
was supported by police and most drug and mental health charities.

The council's unpublished report is said to have concluded that the risk
of someone developing schizophrenia as a result of using cannabis was
"very small".

It is believed to have said it was a "substantially less" harmful drug
than those currently classified as class B, including amphetamines such
as speed and barbiturates.

Cliff Prior, the chief executive of the mental health charity Rethink,
welcomed the decision to better educate the public about the links
between cannabis use and mental ill health.

"We want people to have the clearest possible understanding of the link
between long-term and early age use of cannabis and schizophrenia," he said.

"This is a huge public health issue with potentially serious
consequences for many thousands of the four million regular cannabis
users in this country."

Mr Clarke ordered a review of the 2004 reclassification of cannabis last
year when he admitted the change had confused the public about the
drug's legal status and health risks.

Following the reclassification, a series of health studies warned that
cannabis could be linked to schizophrenia and depression.

One, carried out in New Zealand, suggested regular cannabis use
increased the risk of developing psychotic symptoms later in life.

Another report, from Maastricht University, concluded that taking the
drug "moderately increased" the chance of psychotic symptoms in young
people, but added that it had "a much stronger effect in those with
evidence of predisposition for psychosis".

 

 

 

After you have finished reading this article you can click here to go back.




This page was created by the Cannabis Campaigners' Guide.
Feel free to link to this page!